Bonthuis D C, Landheer M L E A, Spillenaar Bilgen E J, Slootmans F C W, van Lier H, Klinkenbijl J H G, Wobbes Th
Department of Surgery, Rijnstate Hospital, P.O. Box 9555, 6800 TA Arnhem, The Netherlands.
Eur J Surg Oncol. 2004 Dec;30(10):1093-7. doi: 10.1016/j.ejso.2004.06.018.
The benefit of follow-up for patients after resection of primary colorectal cancer is unproven. The aim of this study was to evaluate the value of a standardised follow-up program considering detection of recurrent disease, eligibility for surgical treatment and survival.
Five hundred and sixty-four patients' records were evaluated. Detection of recurrent disease was distinguished in routine follow up (RF), interval visit (IV) or accidental finding (AF).
One hundred and forty-nine patients (26%) had recurrent disease of which 68 were detected by routine follow-up. In 42 patients a resection was performed with curative intent (RF 18, IV 14, AF 10). In 26 patients radical resection (R(0)) was possible (RF 13, IV 5, AF 8), seven of them were long-term survivors. Routine follow-up itself had no significant influence on overall survival (P=0.08), although increased survival was observed if recurrent disease was detected by routine follow-up and resection was performed with curative intent (P=0.006). Median survival after resection was 4.2 years if recurrent disease was detected during routine follow-up and 0.5 years if detected during interval visits.
Patients undergoing resection with curative intent for recurrent disease survive significantly longer if the disease is detected by routine follow-up. Routine follow-up itself did not improve overall survival.
原发性结直肠癌切除术后对患者进行随访的益处尚未得到证实。本研究的目的是评估标准化随访计划在检测复发性疾病、手术治疗的适用性和生存率方面的价值。
评估了564例患者的记录。复发性疾病的检测分为常规随访(RF)、间隔期就诊(IV)或偶然发现(AF)。
149例患者(26%)出现复发性疾病,其中68例通过常规随访检测到。42例患者进行了根治性切除(RF 18例,IV 14例,AF 10例)。26例患者可行根治性切除(R(0))(RF 13例,IV 5例,AF 8例),其中7例为长期存活者。常规随访本身对总生存率无显著影响(P = 0.08),尽管如果通过常规随访检测到复发性疾病并进行了根治性切除,则观察到生存率提高(P = 0.006)。如果在常规随访期间检测到复发性疾病,切除术后的中位生存期为4.2年;如果在间隔期就诊时检测到,则为0.5年。
对于复发性疾病接受根治性切除的患者,如果通过常规随访检测到疾病,其生存期显著延长。常规随访本身并未改善总生存率。